Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.23736/S0031-0808.19.03752-2 | DOI Listing |
Int J Environ Res Public Health
February 2023
Population Cancer Registry in Lleida, Santa Maria University Hospital, Av. Alcalde Rovira Roure 44, 25198 Lleida, Spain.
Excess weight, smoking and risky drinking are preventable risk factors for colorectal cancer (CRC). However, several studies have reported a protective association between aspirin and the risk of CRC. This article looks deeper into the relationships between risk factors and aspirin use with the risk of developing CRC.
View Article and Find Full Text PDFPLoS One
January 2022
Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Importance: Levothyroxine prescriptions are rising worldwide. However, there are few data on factors associated with chronic use.
Objective: To assess the prevalence of chronic levothyroxine use, its rank among other chronic drugs and factors associated with chronic use.
Curr Med Res Opin
March 2021
Department of Medicine, Universitat Autonoma de Barcelona, Barcelona, Spain.
Objective: To analyze the temporal trends of atrial fibrillation (AF)-related ischemic stroke (IS) and their relationship with the prescription patterns of antithrombotic treatment from 2013 to 2019 in the Health Assistance Area of a regional hospital.
Methods: First, a retrospective ecological study of aggregate data to analyze the annual incidence of IS between 2013 and 2019 was performed. Second, we selected those patients diagnosed with AF between 2013 and 2019 and performed a retrospective longitudinal study to assess the role of antithrombotic therapy in the development of AF-related IS.
Panminerva Med
September 2019
Department of Hepatobiliary Surgery, Affiliated Hospital of Binzhou Medical College, Binzhou, China -
Eur J Prev Cardiol
May 2019
2 ReS (Research & Health) Foundation, Rome, Italy.
Aims: Current guidelines strongly recommend antiplatelet therapy with aspirin plus a P2Y receptor inhibitor (dual therapy) for patients with acute coronary syndrome (ACS). To better understand how antiplatelet treatment is prescribed in clinical practice, the aim of this study was to provide a more detailed description of real-world patients with and without antiplatelet treatment after an ACS, their outcomes at one-year follow-up and the related integrated cost.
Methods: The ReS database, including more than 12 million inhabitants, was evaluated.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!